Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M354Revenue $M34.7Net Margin (%)-55.3Z-Score-35.5
Enterprise Value $M335EPS $-0.4Operating Margin %-48.6F-Score6
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-56.3Higher ROA y-yY
Price/Book18.210-y EBITDA Growth Rate %-46.4Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %-45.4Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-61.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-204.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M150ROI % (ttm)-75.7Gross Margin Increase y-yY

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CTIC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Plunkett MatthewEVP, Corporate Development 2014-12-04Sell12,000$2.235.83view
BIANCO LOUIS AEVP, Finance & Administration 2014-12-04Sell10,000$2.254.89view
BIANCO LOUIS AEVP, Finance & Administration 2014-11-06Sell10,000$2.37-0.42view
Plunkett MatthewEVP, Corporate Development 2014-11-04Sell12,000$2.39-1.26view
Plunkett MatthewEVP, Corporate Development 2014-10-06Sell12,000$2.39-1.26view
Plunkett MatthewEVP, Corporate Development 2014-09-23Sell103,635$2.56-7.81view
BIANCO JAMES APresident and CEO 2014-09-22Sell307,068$2.53-6.72view
BIANCO LOUIS AEVP, Finance & Administration 2014-09-19Sell145,000$2.59-8.88view
Plunkett MatthewEVP, Corporate Development 2014-09-04Sell27,301$2.48-4.84view
BIANCO JAMES APresident and CEO 2014-08-15Sell40,000$2.54-7.09view

Press Releases about CTIC :

    Quarterly/Annual Reports about CTIC:

    News about ctic:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    comment on CTIC Dec 16 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

    More From Other Websites
    CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Dec 11 2014
    CTI BIOPHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 09 2014
    CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated... Dec 09 2014
    CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated... Dec 09 2014
    CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases... Dec 06 2014
    CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases... Dec 06 2014
    CTI BIOPHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 04 2014
    CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® Dec 04 2014
    Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off Dec 02 2014
    CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting Dec 01 2014
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Nov 26 2014
    CTI BioPharma to Present at the Upcoming Investor Conferences Nov 17 2014
    CTI BioPharma to Present at the Upcoming Investor Conferences Nov 17 2014
    CTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... Nov 13 2014
    CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock Nov 07 2014
    CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock Nov 07 2014
    CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock Nov 06 2014
    CTI BIOPHARMA CORP Files SEC form 8-K/A, Financial Statements and Exhibits Nov 06 2014
    CTI BIOPHARMA CORP Financials Nov 06 2014
    10-Q for CTI BioPharma Corp. Nov 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK